1. Cavazzana, Marina 法国 Paris University Medical School 2019美国医学院院士 Detrimental effects of sickle cell disease and hydroxycarbamide on ovarian reserve but uncertain imp..
2. 郎景和 中国 中国医学科学院 中国工程院院士 Exploring the cellular and molecular differences between ovarian clear cell carcinoma and high-grade..
3. Graham C. Walker 美国 Massachusetts Institute of Technology 2013美国科学院院士 Inhibition of mutagenic translesion synthesis: A possible strategy for improving chemotherapy?
4. Robert B. Darnell 美国 The Rockefeller University 2010美国医学院院士;2014美国科学院院士 Successful Targeted Therapy of Refractory Pediatric ETV6-NTRK3 Fusion-Positive Secretory Breast Carc..
5. 江涛 中国 首都医科大学 2023中国工程院院士 A RAD52 genetic variant located in a miRNA binding site is associated with glioma risk in Han Chines..
6. Emad A,Rakha 英国 University of Nottingham Tumour 63 protein (p63) in breast pathology: biology, immunohistochemistry, diagnostic applications,..
7. 邵志敏 中国 复旦大学上海医学院 Secretory breast carcinoma: clinicopathological features and prognosis of 52 patients
8. Gabriel,Lopez-Berestein 美国 University of Texas MD Anderson Cancer Center Aptamers as Potential Therapeutic Tools for Ovarian Cancer: Advancements and Challenges
9. Asif,Rashid 美国 University of Texas MD Anderson Cancer Center Müllerian-Type Clear Cell Carcinoma of Donor Origin in a Male Patient with a Kidney Transplant: Asc..
10. David,Cibula 捷克共和国 Charles University Prague HER2 status as a potential predictive biomarker for ovarian clear cell carcinoma
11. David,Cibula 捷克共和国 Charles University Prague Microsatellite instability in non-endometrioid ovarian epithelial tumors: a study of 400 cases compa..
12. Cheng, Liang 美国 Indiana University Triple-negative Breast Carcinoma With Apocrine and Histiocytoid Features
13. Sung-Bae,Kim 韩国 University of Ulsan Prognostic implications of HER2 changes after neoadjuvant chemotherapy in patients with HER2-zero an..
14. Ben Willem J,Mol 荷兰 University of AMSTERDAM Community awareness and use of anti-Mullerian hormone testing in Australia: a population survey of w..
15. Aysegul A,Sahin 美国 University of Texas MD Anderson Cancer Center Nuclear staining for pan-Trk by immunohistochemistry is highly specific for secretory carcinoma of b..
16. Antonio Simone,Lagana 意大利 University of Insubria Upgrading Treatment and Molecular Diagnosis in Endometrial Cancer-Driving New Tools for Endometrial ..
17. Ettore,Cicinelli 意大利 University of Bari Upgrading Treatment and Molecular Diagnosis in Endometrial Cancer-Driving New Tools for Endometrial ..
18. Ruby Yun-Ju,Huang 中国 国立台湾大学 Immune-Hot tumor features associated with recurrence in early-stage ovarian clear cell carcinoma
19. Ursula A,Matulonis 美国 Harvard University DKK1 is a predictive biomarker for response to DKN-01: Results of a phase 2 basket study in women wi..
20. Michael J,Birrer 美国 University of ALABAMA DKK1 is a predictive biomarker for response to DKN-01: Results of a phase 2 basket study in women wi..